Just recently, the American Diabetes Association updated their guidelines to include the recommendation that certain Type 2 Diabetics add to their regimen one of two medications shown to lower the risk of death from stroke and heart disease. Here is the update:
If you are a type 2 diabetic with established heart disease, aka atherosclerotic cardiovascular disease, and your target blood sugars aren’t being met with metformin and diet/exercise add Victoza injections 0r Jardiance.
- Jardiance, a pill taken once daily, is indicated in type 2 diabetes patients with established heart disease who aren’t well controlled despite metformin and lifestyle changes. Jardiance received an indication for improving survival in adults with type 2 diabetes and heart disease by the FDA in December 2016 and was the first medication to do so.
- Victoza injection once daily received the FDA indication for “prevention of cardiovascular events as well as death” in August 2017. By how much? Victoza has been shown to reduce the risk of death, heart attack or stroke in diabetics by 13% compared with placebo.
Which one should you choose? Victoza, or? Well, Jardiance is a pill and not a shot. Just sayin’. Victoza injections of 1.2 or 1.8 mg do help for weight loss, and in fact, the 3 mg injection dosage of liraglutide, Saxenda, is FDA approved for weight loss.
What’s the downside? Cost. Both Victoza and Jardiance are expensive and often require prior authorization forms to be filled out by your doctor (I know because I do them every day). With these new ADA recommendations, the hope is both will be covered without requiring such a fight.
Anyone on these already?